Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 05:51:24 UTC |
---|
Update Date | 2016-11-09 01:15:56 UTC |
---|
Accession Number | CHEM019145 |
---|
Identification |
---|
Common Name | Ceftizoxime sodium |
---|
Class | Small Molecule |
---|
Description | The sodium salt of ceftizoxime. |
---|
Contaminant Sources | - ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
Ceftizoxim-natrium | ChEBI | CZX | ChEBI | Cefizox | Kegg | Epocelin | Kegg | SK And F 883732 | MeSH | Fujiwasa brand OF cetizoxime sodium | MeSH | Monosodium salt, ceftizoxime | MeSH | Ceftizoxime | MeSH | GlaxoSmithKline brand OF cetizoxime sodium | MeSH | SK And F 88373 2 | MeSH | Ceftizoxime monosodium salt | MeSH | Sodium, ceftizoxime | MeSH | Yamanouchi brand OF ceftizoxime sodium | MeSH | Salt, ceftizoxime monosodium | MeSH | SK And F 88373-2 | MeSH |
|
---|
Chemical Formula | C13H12N5NaO5S2 |
---|
Average Molecular Mass | 405.380 g/mol |
---|
Monoisotopic Mass | 405.018 g/mol |
---|
CAS Registry Number | 68401-82-1 |
---|
IUPAC Name | sodium (2Z)-N-[(6R,7R)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(2-imino-2,3-dihydro-1,3-thiazol-4-yl)-2-(methoxyimino)ethanecarboximidate |
---|
Traditional Name | sodium (2Z)-N-[(6R,7R)-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(2-imino-3H-1,3-thiazol-4-yl)-2-(methoxyimino)ethanecarboximidate |
---|
SMILES | [Na+].[H][C@]12SCC=C(N1C(=O)[C@@]2([H])N=C([O-])C(=N/OC)\C1=CSC(=N)N1)C(O)=O |
---|
InChI Identifier | InChI=1S/C13H13N5O5S2.Na/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18;/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22);/q;+1/p-1/b17-7-;/t8-,11-;/m1./s1 |
---|
InChI Key | ADLFUPFRVXCDMO-LIGXYSTNSA-M |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as n-acyl-alpha amino acids and derivatives. N-acyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha amino acid or derivatives
- Cephem
- Meta-thiazine
- Azole
- Beta-lactam
- Heteroaromatic compound
- Tertiary carboxylic acid amide
- Thiazole
- Azetidine
- Carboxamide group
- Isothiourea
- Lactam
- Carboximidic acid
- Carboximidic acid derivative
- Carboxylic acid
- Azacycle
- Organic alkali metal salt
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Dialkylthioether
- Thioether
- Hemithioaminal
- Propargyl-type 1,3-dipolar organic compound
- Organic 1,3-dipolar compound
- Organic sodium salt
- Carbonyl group
- Organic nitrogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic salt
- Hydrocarbon derivative
- Organic oxygen compound
- Organic zwitterion
- Organopnictogen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-029f-1947100000-5e6d87fd73d9e2ffa593 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4m-1921000000-793c1d22820d0965bf9b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0kam-4910000000-98fa2b3b0b69ba431f2e | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-000i-0090000000-b15e46ef3e0eceea3402 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4r-2596000000-d22d4c99998b1a1d6168 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-052f-9210000000-0fc5ad718873cc3d9ac1 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DBSALT001162 |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Ceftizoxime |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | 3512 |
---|
PubChem Compound ID | 9690094 |
---|
Kegg Compound ID | C08118 |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|